companydata.dkcompanydata.dk

NORDIC BIOTECH K/S: Financial statements 2021

CVR: 26290724

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

NORDIC BIOTECH K/S (CVR 26290724) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -6,387,000 compared with DKK -1,360,000 the year before. Equity in the 2021 report amounted to DKK 78,722,000. The solvency ratio was 99.9%.

Profit/Loss
DKK -6,387,000
Equity
DKK 78,722,000
Total Assets
DKK 78,784,000
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021---6.4M78.7M0
2020---1.4M85.1M0
2019--13M86.5M0
2018---464.7M73.5M-
2017--149.6M538.1M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like NORDIC BIOTECH K/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

NORDIC BIOTECH K/S: The 2020 annual report is outMay 12, 2021

NORDIC BIOTECH K/S has published its annual report for 2020. The net result was DKK -1,360,000.

About NORDIC BIOTECH K/S

NORDIC BIOTECH K/S was a Danish company of the type Kommanditselskab based in Hellerup, founded in 2001. The company has been dissolved on 22 December 2025. The company was registered under the industry Anden finansiel formidling i.a.n.. The company has 0 employees (2011). In 2024, the company reported a gross profit of DKK -157,000 and a net result of DKK 101,458,000 compared with DKK 1,254,000 the year before. Equity in the 2024 report amounted to DKK 127,032,000.

Source: annual report 2024, Danish Business Authority